Catapult Therapeutics is a privately held Dutch biotech company developing CAP-100 – an innovative first-in-class humanized anti-CCR7 antibody.
View Top Employees from Catapult Therapeutics| Website | https://www.catapult-therapeutics.com/ |
| Revenue | $200000 |
| Employees | 2 (2 on RocketReach) |
| Founded | 2015 |
| Industry | Biotechnology, Biotechnology Research, Business Services General, Drug Discovery, Business Services, Science and Engineering |
| SIC | SIC Code 873 Companies, SIC Code 87 Companies |
| NAICS | NAICS Code 541 Companies, NAICS Code 5417 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541713 Companies |
Looking for a particular Catapult Therapeutics employee's phone or email?
Catapult Therapeutics Questions
The Catapult Therapeutics annual revenue was $200000 in 2024.
2 people are employed at Catapult Therapeutics.
Catapult Therapeutics is based in 's-Hertogenbosch, Noord-Brabant.
The NAICS codes for Catapult Therapeutics are [541, 5417, 54171, 54, 541713].
The SIC codes for Catapult Therapeutics are [873, 87].
Top Catapult Therapeutics Employees
-
11
-
2
Related Companies
